Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of Packaging, Type of Delivery, Indication, and End User

List of Tables

The global lyophilized injectable market is projected to reach US$ 4,001.27 million by 2028 from US$ 2,719.42 million in 2021; it is expected to grow at a CAGR of 5.8% from 2022 to 2028.

The increasing demand for contract research manufacturing services, rising approvals of pharmaceuticals, and growing demand for biologics drive the growth of the market. However, high product recalls hamper the market growth.

Freeze drying, or lyophilization, consists of the sublimation of ice crystals into vapor. Lyophilization is a process based on negative temperatures, the product's activity, and stability, along with active ingredients that are retained while limiting any damage to the product and avoiding any degradation of the molecules. Thus, freeze-drying is especially popular in the pharmaceutical & diagnostic sectors. The increased quality and extended shelf life of lyophilized injectable drugs created growth opportunities for manufacturers to implement the lyophilization process in product manufacturing. The contract manufacturing and research services are in huge demand, delivering lyophilized injectable drugs to offer high-quality products to the end users.

Moreover, many pharmaceutical companies are refocusing on their core capabilities, such as research and development, leading to divestments of in-house manufacturing capacities, which is propelling the demand for contract research manufacturing services (CRAMs) for manufacturing. Furthermore, CRAMs play crucial roles to mitigate the risk of supply shortages by offering additional sites for pharmaceutical companies with multisite supply strategies and backup capacities. For instance, in 2019, Samsung Biologics and GI Innovation signed a contract for immunochemotherapy. Under the agreement, Samsung Biologics provided services ranging from the development of cell line to the production of Phase I drug substances.

Furthermore, the advantages offered by the lyophilized injectables, such as safe transit and extended pharmaceutical storage life, increased the adoption of the lyophilization technique by many enterprises globally.

The global impacts of COVID-19 pandemic are witnessed across several markets. Due to stringent lockdown and movement restrictions, clinical trials were temporarily halted. In the healthcare sector, the focus was shifted primarily to the treatment of COVID-19 patients and the development of the COVID-19 vaccine. All these factors had a positive impact on market growth in the initial phase of pandemic.

There was an unusual demand for Remdesivir, an antiviral medicine used to treat patients, during the peak of the COVID-19 outbreak. Manufacturers in the lyophilized injectables market are preparing for the future by keeping adequate supply chains to avoid any COVID-19-like vulnerabilities. Gilead Sciences and other big pharma companies received an Emergency Use Authorization (EUA) by the US FDA for the use of remdesivir for the treatment of hospitalized COVID-19 patients. Further, in May 2020, Gilead Sciences Inc. extended a voluntary nonexclusive license to Cipla to manufacture and market Cipla's generic version of remdesivir called CIPREMI. Companies are utilizing government programs and financing schemes given by the BFSI industry to streamline their operations in response to turbulent market conditions. For instance, in May 2020, the US government entered an agreement with a group of American generic medicine manufacturers potentially worth US$ 812 million to bolster the country's drug supply amid the pandemic. Thus, the growing demand for drugs due to the COVID-19 pandemic bolstered the global lyophilized injectable market.

Geography-Based Insights

North America holds the largest share of the global lyophilized injectable market, whereas Asia Pacific is the fastest-growing region. The market in North America is expected to grow during the forecast period owing to the increasing demand for lyophilized injectables for safe packaging and prolonged shelf life, growing pharmaceutical production due to the COVID-19 pandemic, and rising research and development in the healthcare industry.

During 2022-2028, Asia Pacific is likely to register the highest CAGR in the global lyophilized injectable market. The market in the region is expected to grow significantly in countries, including China, India, and Japan, in the coming years. The growing research & development activities due to the increase in the investments by biotechnology, pharmaceutical, and biopharmaceutical companies and rising applications of lyophilized injectable drug in various fields are among the factors propelling the demand for lyophilized injectables in Asia Pacific.

Type of Packaging- Based Insights

The global lyophilized injectable market, based on type of packaging, is segmented into single-use vials, point-of-care reconstitution, and specialty packaging. In 2021, the single-use vials segment accounted for the largest market share, whereas the specialty packaging segment is expected to register the highest CAGR of 6.7% during the forecast period.

Type of Delivery- Based Insights

Based on type of delivery, the global lyophilized injectable market is segmented into prefilled diluent syringes, proprietary reconstitution devices, single-step devices, and multi-step devices. The prefilled diluent syringes segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.3% during the forecast period.

Indication- Based Insights

Based on indication, the global lyophilized injectable market is segmented into metabolic and oncology conditions, infectious diseases, autoimmune diseases, and other indications. The metabolic and oncology conditions segment held the largest market share in 2021 and is anticipated to register the highest CAGR of 6.2% during the forecast period.

End User- Based Insights

Based on end user, the global lyophilized injectable market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. The hospitals segment held the largest market share in 2021. However, the specialty clinics segment is estimated to register the highest CAGR of 6.3% in the market during the forecast period.

The World Health Organization (WHO), Globocan, World Bank Data, National Health Service (NHS), National Library of Medicine (NLM), and Association for the Advancement of Medical Instrumentation are a few secondary sources referred to while preparing the report on the global lyophilized injectable market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the lyophilized injectable market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the lyophilized injectable market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhancing the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00004411

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Lyophilized Injectable Market - By Type of Packaging
- 1.3.2 Global Lyophilized Injectable Market - By Type of Delivery
- 1.3.3 Global Lyophilized Injectable Market - By Indication
- 1.3.4 Global Lyophilized Injectable Market - By End User
- 1.3.5 Global Lyophilized Injectable Market - By Geography

2. Lyophilized Injectable Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Lyophilized Injectable Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America PEST Analysis
- 4.2.2 Europe PEST Analysis
- 4.2.3 Asia Pacific PEST Analysis
- 4.2.4 Middle East and Africa PEST Analysis
- 4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion

5. Lyophilized Injectable Market- Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Demand for Contract Research Manufacturing Services
- 5.1.2 Rising Approvals of Pharmaceuticals
- 5.1.3 Increasing Demand of Biologics
5.2 Market Restraints
- 5.2.1 Product Recalls
5.3 Market Opportunities
- 5.3.1 Expansion of Pipeline of Lyophilized Injectable Drugs
5.4 Future Trends
- 5.4.1 Advancement in Lyophilized Packaging
5.5 Impact Analysis

6. Lyophilized Injectable Market- Global Analysis

6.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
- 6.1.1 Global Lyophilized Injectable Market Revenue Forecast And Analysis
- 6.1.2 Global Lyophilized Injectable Market - Market Potential Analysis, by Region
6.2 Comparative Company Analysis
6.3 Growth Strategy Analysis
6.4 Market Positioning Analysis of Key Players in Lyophilized Injectable Market
6.5 Performance of Key Players
6.6 Market Share Analysis
6.7 Top 3 Lyophilized Drug Products (ASP) (2021)

7. Lyophilized Injectable Market Analysis - By Type of Packaging

7.1 Overview
7.2 Lyophilized Injectable Market Revenue Share, by Type of Packaging (2021 and 2028)
7.3 Single-use vials
- 7.3.1 Overview
- 7.3.2 Single-use vials: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Point-of-Care Reconstitution
- 7.4.1 Overview
- 7.4.2 Point-of-Care Reconstitution: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Specialty Packaging
- 7.5.1 Overview
- 7.5.2 Specialty Packaging: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

8. Lyophilized Injectable Market Analysis - By Type Of Delivery

8.1 Overview
8.2 Lyophilized Injectable Market Revenue Share, by Type of Delivery (2021 and 2028)
8.3 Prefilled Diluent Syringes
- 8.3.1 Overview
- 8.3.2 Prefilled Diluent Syringes: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Single Step Devices
- 8.4.1 Overview
- 8.4.2 Single Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Proprietary Reconstitution Devices
- 8.5.1 Overview
- 8.5.2 Proprietary Reconstitution Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Multi-Step Devices
- 8.6.1 Overview
- 8.6.2 Multi-Step Devices: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

9. Lyophilized Injectable Market Analysis - By Indication

9.1 Overview
9.2 Lyophilized Injectable Market Revenue Share, by Indication (2021 and 2028)
9.3 Metabolic and Oncology Conditions
- 9.3.1 Overview
- 9.3.2 Metabolic and Oncology Conditions: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Infectious Diseases
- 9.4.1 Overview
- 9.4.2 Infectious Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Autoimmune Diseases
- 9.5.1 Overview
- 9.5.2 Autoimmune Diseases: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
9.6 Other Indications
- 9.6.1 Overview
- 9.6.2 Other Indications: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

10. Lyophilized Injectable Market -By End User

10.1 Overview
10.2 Lyophilized Injectable Market, by End User, 2021 and 2028 (%)
10.3 Hospitals
- 10.3.1 Overview
- 10.3.2 Hospitals: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Specialty Clinics
- 10.5.1 Overview
- 10.5.2 Specialty Clinics: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
10.6 Other End Users
- 10.6.1 Overview
- 10.6.2 Other End Users: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)

11. Lyophilized Injectable Market Revenue and Forecasts to 2028 - Geographical Analysis

11.1 North America: Lyophilized Injectable Market
- 11.1.1 Overview
- 11.1.2 North America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
- 11.1.3 North America: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
- 11.1.4 North America: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
- 11.1.5 North America: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
- 11.1.6 North America: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
- 11.1.7 North America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.1.7.1 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.1 Overview
    - 11.1.7.1.2 US: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.3 US: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
    - 11.1.7.1.4 US: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.7.1.5 US: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.7.1.6 US: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.1 Overview
    - 11.1.7.2.2 Canada: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.3 Canada: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
    - 11.1.7.2.4 Canada: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.7.2.5 Canada: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.7.2.6 Canada: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.1.7.3 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.1 Overview
    - 11.1.7.3.2 Mexico: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.3 Mexico: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ Million)
    - 11.1.7.3.4 Mexico: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.1.7.3.5 Mexico: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.1.7.3.6 Mexico: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.2 Europe: Lyophilized Injectable Market
- 11.2.1 Overview
- 11.2.2 Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
- 11.2.3 Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
- 11.2.4 Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
- 11.2.5 Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
- 11.2.6 Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
- 11.2.7 Europe: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.2.7.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.1.1 Overview
    - 11.2.7.1.1 Germany: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.1.2 Germany: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.1.3 Germany: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.1.4 Germany: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.1.5 Germany: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.2.7.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.2.1 Overview
    - 11.2.7.2.2 UK: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.2.3 UK: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.2.4 UK: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.2.5 UK: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.2.6 UK: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.2.7.3 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.3.1 Overview
    - 11.2.7.3.2 France: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.3.3 France: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.3.4 France: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.3.5 France: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.3.6 France: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.2.7.4 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.4.1 Overview
    - 11.2.7.4.2 Italy: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.4.3 Italy: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.4.4 Italy: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.4.5 Italy: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.4.6 Italy: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.2.7.5 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.5.1 Overview
    - 11.2.7.5.2 Spain: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.5.3 Spain: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.5.4 Spain: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.5.5 Spain: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.5.6 Spain: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.2.7.6 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.6.1 Overview
    - 11.2.7.6.2 Rest of Europe: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.2.7.6.3 Rest of Europe: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
    - 11.2.7.6.4 Rest of Europe: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
    - 11.2.7.6.5 Rest of Europe: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.2.7.6.6 Rest of Europe: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
11.3 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts To 2028
- 11.3.1 Overview
- 11.3.2 Asia Pacific Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
- 11.3.3 Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
- 11.3.4 Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
- 11.3.5 Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
- 11.3.6 Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
- 11.3.7 Asia Pacific: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.3.7.1 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.1 Overview
    - 11.3.7.1.2 China: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.1.3 China: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.1.4 China: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.1.5 China: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.1.6 China: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.3.7.2 India Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.1 Overview
    - 11.3.7.2.2 India: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.2.3 India: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.2.4 India: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.2.5 India: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.2.6 India: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.3.7.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.1 Overview
    - 11.3.7.3.2 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.3.3 Japan: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.3.4 Japan: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.3.5 Japan: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.3.6 Japan: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.3.7.4 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.1 Overview
    - 11.3.7.4.2 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.4.3 South Korea: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.4.4 South Korea: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.4.5 South Korea: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.4.6 South Korea: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.3.7.5 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.1 Overview
    - 11.3.7.5.2 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.7.5.3 Australia: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.5.4 Australia: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.5.5 Australia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.5.6 Australia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
  - 11.3.7.6 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.1 Overview
    - 11.3.7.6.2 Rest of Asia Pacific: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.7.6.3 Rest of Asia Pacific: Lyophilized Injectable Market Revenue and Forecasts to 2028, By Type of Packaging (US$ Million)
    - 11.3.7.6.4 Rest of Asia Pacific: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ Million)
    - 11.3.7.6.5 Rest of Asia Pacific: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ Million)
    - 11.3.7.6.6 Rest of Asia Pacific: Lyophilized Injectable Market, by End User, 2019-2028 (US$ Million)
11.4 South and Central America Lyophilized Injectable Market
- 11.4.1 Overview
- 11.4.2 South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
- 11.4.3 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Packaging (US$ Million)
- 11.4.4 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Type of Delivery (US$ Million)
- 11.4.5 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by Indication (US$ Million)
- 11.4.6 South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, by End User (US$ Million)
- 11.4.7 South and Central America: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.4.7.1 Brazil: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 Brazil Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
    - 11.4.7.1.3 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
    - 11.4.7.1.4 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
    - 11.4.7.1.5 Brazil: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
    - 11.4.7.1.6 Brazil: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.4.7.2 Argentina: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 Argentina Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
    - 11.4.7.2.3 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
    - 11.4.7.2.4 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
    - 11.4.7.2.5 Argentina: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
    - 11.4.7.2.6 Argentina: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
  - 11.4.7.3 Rest of the South and Central America: Lyophilized Injectable Market - Revenue and Forecast to 2028 (USD Million)
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 Rest of the South and Central America Lyophilized Injectable Market Revenue and Forecast to 2028 (US$ Million)
    - 11.4.7.3.3 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Type of Packaging (US$ Million)
    - 11.4.7.3.4 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By Type of Delivery (US$ Million)
    - 11.4.7.3.5 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast to 2028, By Indication (US$ Million)
    - 11.4.7.3.6 Rest of the South and Central America: Lyophilized Injectable Market Revenue and Forecast To 2028, By End User (US$ Million)
11.5 Middle East & Africa Lyophilized Injectable Market Revenue and Forecasts To 2028
- 11.5.1 Overview
- 11.5.2 Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
- 11.5.3 Middle East and Africa: Lyophilized Injectable Market, by Type of Packaging, 2019-2028 (US$ 'Million)
- 11.5.4 Middle East and Africa: Lyophilized Injectable Market, by Type of Delivery, 2019-2028 (US$ 'Million)
- 11.5.5 Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
- 11.5.6 Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
- 11.5.7 Middle East and Africa: Lyophilized Injectable Market, by Country, 2021 & 2028 (%)
  - 11.5.7.1 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.1.1 Overview
    - 11.5.7.1.2 South Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.1.3 South Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
    - 11.5.7.1.4 South Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
    - 11.5.7.1.5 South Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.5.7.1.6 South Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.5.7.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.2.1 Overview
    - 11.5.7.2.2 Saudi Arabia: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.2.3 Saudi Arabia: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
    - 11.5.7.2.4 Saudi Arabia: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
    - 11.5.7.2.5 Saudi Arabia: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.5.7.2.6 Saudi Arabia: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.5.7.3 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.3.1 Overview
    - 11.5.7.3.2 UAE: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.3.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
    - 11.5.7.3.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
    - 11.5.7.3.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.5.7.3.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)
  - 11.5.7.4 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.4.1 Overview
    - 11.5.7.4.2 Rest of Middle East and Africa: Lyophilized Injectable Market - Revenue and Forecast to 2028 (US$ 'Million)
    - 11.5.7.4.3 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Packaging, 2019-2028 (US$ 'Million)
    - 11.5.7.4.4 Rest of Middle East and Africa: Lyophilized Injectable Market, by Type Of Delivery, 2019-2028 (US$ 'Million)
    - 11.5.7.4.5 Rest of Middle East and Africa: Lyophilized Injectable Market, by Indication, 2019-2028 (US$ 'Million)
    - 11.5.7.4.6 Rest of Middle East and Africa: Lyophilized Injectable Market, by End User, 2019-2028 (US$ 'Million)

12. Impact of COVID-19 Pandemic on Global Lyophilized Injectable Market

12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 South and Central America: Impact Assessment of COVID-19 Pandemic
12.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13. Lyophilized Injectable Market-Industry Landscape

13.1 Overview
13.2 Growth Strategies in the Lyophilized Injectable Market
13.3 Inorganic Growth Strategies
- 13.3.1 Overview
13.4 Organic Growth Strategies
- 13.4.1 Overview

14. Company Profiles

14.1 Baxter
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Nipro
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Curia Global, Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Recipharm AB
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Vetter Pharma
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Jubilant HollisterStier (Jubilant Pharma Limited)
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Aristopharma Ltd.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 CordenPharma International
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Credence MedSystems, Inc.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 S.G. Biopharm Pvt. Ltd.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms